ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "metabolomics"

  • Abstract Number: 1221 • ACR Convergence 2020

    Evaluation of Methotrexate Efficacy and Exploration of Metabolites Associated with Disease Activity in Collagen-induced Arthritis Mouse Model

    Yu Kyoung Cho1 and Ryan Funk1, 1UNIVERSITY OF KANSAS, Kansas City, KS

    Background/Purpose: Methotrexate (MTX) is cornerstone of therapy for rheumatoid arthritis. However, response to MTX is variable and unpredictable among patients. Therefore, there is a critical…
  • Abstract Number: 1517 • ACR Convergence 2020

    Metabolic Regulation of Type 3 Innate Lymphoid Cells by Intestinal Bacteria-Derived Indoles in Ankylosing Spondylitis

    Adam Berlinberg1, Adam Lefferts2, Emilie Regner3, Andrew Stahly4 and Kristine Kuhn4, 1University of Colorado, Denver, CO, 2University of Colorado, Anschutz Medical Campus, Denver, CO, 3University of California San Francisco, San Francisco, CA, 4University of Colorado Anschutz Medical Campus, Aurora, CO

    Background/Purpose: Intestinal microbial dysbiosis, intestinal inflammation, and Th17 immunity are all linked to the pathophysiology of ankylosing spondylitis (AS); however, the mechanisms linking them remain…
  • Abstract Number: 1849 • ACR Convergence 2020

    Identification of New Associations Between Psoriatic Arthritis and the Gut Microbiota. the Mi-PART, a Phenomic Study

    Jesus Miguens Blanco1, Uma Selvarajah1, Zhigang Lui1, Benjamin Mullish1, James Alexander1, Julie McDonald2, Sonya Abraham1 and Julian Marchesi1, 1Imperial College London, London, United Kingdom, 2Imperial College London, London

    Background/Purpose: Perturbations of the gut microbiota have been associated with Psoriatic Arthritis (PsA), a chronic inflammatory disease. We aim to test the microbiome-metabolic interface of…
  • Abstract Number: 0031 • ACR Convergence 2020

    Metabolomics Profiling Predicts Outcome of Tocilizumab in Rheumatoid Arthritis

    Jessica Murillo-Saich1, Cesar Diaz-Torne2, M. Angeles Ortiz2, Roxana Coras1, Arthur Kavanaugh3, Hector Corominas2, Silvia Vidal2 and Monica Guma4, 1University of California San Diego, La Jolla, CA, 2Institut Rec. Hospital de la Santa Creu I Sant Pau., Barcelona, Spain, 3Division of Rheumatology, Allergy, & Immunology, University of California San Diego Medical School, San Diego, CA, 4Division of Rheumatology, University of California San Diego, Department of Medicine, Autonomous University of Barcelona, La Jolla, CA

    Background/Purpose: Metabolomics may provide information about the activity and severity of specific diseases and  potentially help discriminate between diseases. Choosing the right biological therapy earlier…
  • Abstract Number: 1994 • ACR Convergence 2020

    Rheumatoid Arthritis Improvement After Exposure to an Anti-Inflammatory “ITIS” Diet Is Associated with Changes of Gut Microbiome and Systemic Metabolome

    Roxana Coras1, Cameron Martino2, Julia Gauglitz3, Anupriya Tripathi3, Alan Jarmusch4, Francesca Cedola5, Marta Fernandez Bustamante6, Meritxall Agustín-Perez7, Maram Alharthi8, Susan Lee8, Abha Singh8, Soo In Choi8, Tania Rivera8, Katherine Nguyen8, Tatyana Shekhtman9, Tiffany Holt10, Shahrokh Golshan11, Rob Knight3, Pieter Dorrestein12 and Monica Guma13, 1University of California San Diego, La Jolla, CA, 2Bioinformatics and Systems Biology, University of California San Diego, San Diego, 3University of California San Diego, San Diego, 4Univesity of California San Diego, San Diego, 5Hospital Policlinico Tor Vergata, Rome, Italy, 6Departement of Medicine, Division of Rheumatology, University of California San Diego, San Diego, 7Department of Medicine, University of California San Diego, San Diego, San Diego, 8Department of Medicine, Division of Rheumatology, University of California San Diego, San Diego, 9Department of Psychiatry, University of California, San Diego, San Diego, 10Center for Integrative Nutrition, University of California San Diego, San Diego, 11Department of Psychiatry, University of California San Diego, San Diego, CA, USA, San Diego, 12Department of Pharmacology and Pediatrics, University of California San Deigo, San Diego, 13Division of Rheumatology, University of California San Diego, Department of Medicine, Autonomous University of Barcelona, La Jolla, CA

    Background/Purpose: A new dimension has been added to the link between diet and health, the gut microbiome. Of particular interest is the influence of diet…
  • Abstract Number: 0318 • ACR Convergence 2020

    Oxylipin Profile Is Associated with Skin Disease and Enthesitis in Psoriatic Disease

    Roxana Coras1, Arthur Kavanaugh2, Angela Kluzniak3, Dustina Holt3, Amy Weilgosz3, Oswald Quehenberger1, Christopher Ritchlin4 and Monica Guma5, 1University of California San Diego, La Jolla, CA, 2Division of Rheumatology, Allergy, & Immunology, University of California San Diego Medical School, San Diego, CA, 3University of Rochester Medical Center, New York, NY, 4Department of Medicine, University of Rochester Medical Center, Rochester, NY, 5Division of Rheumatology, University of California San Diego, Department of Medicine, Autonomous University of Barcelona, La Jolla, CA

    Background/Purpose: Psoriatic arthritis (PsA), a systemic inflammatory disease, occurs in about 25% of patients with psoriasis (PsO). At present, there are no biomarkers that reliably…
  • Abstract Number: 0472 • ACR Convergence 2020

    ApoB:ApoA1 Ratio Could Predict Atherosclerotic Risk in Juvenile-SLE Patients Associated with Altered Interferon Signalling in CD8+ T-cells

    George Robinson1, Kirsty Waddington2, Leda Coelewij2, Junjie Peng2, Meena Naja2, Chris Wincup2, Anna Radziszewska2, Hannah Peckham2, David Isenberg2, Yiannis Ioannou2, Ines Pineda Torra2, Coziana Ciurtin2 and Elizabeth Jury2, 1University College London, Hertford, United Kingdom, 2University College London, London, United Kingdom

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease characterised by immune-dysregulation, chronic inflammation, type-I interferon (IFN) signatures and increased cardiovascular disease (CVD) risk…
  • Abstract Number: 0503 • ACR Convergence 2020

    Targeted Metabolomic Profiling and Prediction of Cardiovascular Events: A Prospective Study of Patients with Psoriatic Arthritis and Psoriasis

    Keith Colaco1, Ker-Ai Lee2, Shadi Akhtari3, Raz Winer4, Paul Welsh5, Naveed Sattar5, Iain McInnes6, Vinod Chandran7, Paula Harvey8, Richard Cook2, Dafna Gladman7, Vincent Piguet8 and Lihi Eder9, 1Institute of Medical Science, University of Toronto; Women's College Research Institute, Women's College Hospital; and Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 2University of Waterloo, Waterloo, ON, Canada, 3Women's College Hospital, University of Toronto, North York, ON, Canada, 4Rambam Health Care Campus, Haifa, Israel, 5University of Glasgow, Glasgow, Scotland, United Kingdom, 6Institute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow, United Kingdom, 7Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 8Women's College Hospital, University of Toronto, Toronto, ON, Canada, 9Women’s College Research Institute, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Psoriatic arthritis and psoriasis, collectively termed psoriatic disease (PsD), are associated with increased cardiovascular (CV) risk. Metabolites comprise biomarkers that may add predictive value…
  • Abstract Number: 022 • 2020 Pediatric Rheumatology Symposium

    Association of Plasma Metabolomic Profiles with Methotrexate Response in Juvenile Idiopathic Arthritis

    Ryan Funk1 and Mara Becker 2, 1University of Kansas, Leawood, Kansas, 2Duke University Medical Center/Duke Clinical Research Institute, Chapel Hill

    Background/Purpose: Despite efforts to identify biomarkers to guide therapy in the treatment of juvenile idiopathic arthritis (JIA), drug therapy remains a trial-and-error process. In the…
  • Abstract Number: 115 • 2020 Pediatric Rheumatology Symposium

    Carbohydrate and Sugar Intake Predict Pain in Teens with Active JIA Disease but Not in Teens in Remission or Controls: A Cross-Sectional, Case-Control Metabolomics Pilot Study

    Kimberly Lewis1, Nico Osier 2, Patricia Carter 3, Christina Nguyen 4, Ruy Carrasco 5, Shelby Brooks 2, Alexandra Garcia 6 and Stefano Tiziani 5, 1The University of Texas at Austin, Austin, Texas, 2The University of Texas at Austin, Austin, 3University of Alabama, Tuscalossa, 4Ascension Seton Nursing Research, Austin, 5The University of Texas at Austin, Dell Medical School, Austin, 6The University of Texas at Austin, Dell Medical School, School of Nursing, Austin

    Background/Purpose: The purpose of this study is to define the relationships between pain and carbohydrate metabolism in teens with active juvenile idiopathic arthritis (JIA), teens…
  • Abstract Number: 156 • 2020 Pediatric Rheumatology Symposium

    Metabolic Profiling in Juvenile Dermatomyositis

    Jeffrey Dvergsten1, Olga Ilkayeva 2, Lawrence Landerman 2, Michael Muehlbauer 3, David Pisetsky 4, Ann Reed 3 and Kim Huffman 5, 1Duke University Hospital, Hillsborough, 2Duke University, Durham, NC, 3Duke University, Durham, 4Duke University Medical Center, Durham, 5Durham

    Background/Purpose: Investigators have made significant progress piecing together pathogenic mechanisms of juvenile dermatomyositis (DM).  However, this remains an incomplete puzzle, and optimal approaches to diagnosing,…
  • Abstract Number: 1870 • 2019 ACR/ARP Annual Meeting

    NMR-Based Serum, Urine and Muscle Metabolomics in Inflammatory Myositis for Diagnosis and Activity Assessment: Serum Metabolomics Can Differentiate Active from Inactive Myositis

    Latika Gupta1, Dinesh Kumar 2, Umesh Kumar 3, Anupam Guleria 2, Abhishek Zanwar 4, Ritu Raj 5 and Ramnath Misra 1, 1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Lucknow, Uttar Pradesh, India, 2Centre for Biomedical Research, Sanjay Gandhi Post Graduate Institute of Medical Science, Lucknow, Uttar Pradesh, India, 3Centre of Biomedical Research SGPGIMS, Raibareli Road, Lucknow-226014, India, Lucknow, Uttar Pradesh, India, 4Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 5Centre of Biomedical Research, Lucknow, Uttar Pradesh, India

    Background/Purpose: Differentiating smouldering disease activity from weakness due to fatty replacement of atrophied muscle can often be a challenge in Idiopathic Inflammatory Myositis (IIM). There…
  • Abstract Number: 1947 • 2019 ACR/ARP Annual Meeting

    Integrating Genetic Risk Scores and Pre-Diagnostic Metabolomics to Infer Dysregulated Mechanisms in Rheumatoid Arthritis in Women

    Su H. Chu1, Jing Cui 2, Jeffrey Sparks 2, Bing Lu 2, Clary Clish 3, Jessica Lasky-Su 1, Elizabeth Karlson 2 and Karen Costenbader 2, 1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Broad Institute of MIT and Harvard, Boston, MA

    Background/Purpose: Rheumatoid arthritis genetic risk scores (RA-GRS) improve RA risk prediction, but the added predictive value over lifestyle risk factors is modest. Several human leukocyte…
  • Abstract Number: 2127 • 2019 ACR/ARP Annual Meeting

    Diagnosis of Inflammatory Rheumatic Diseases: Preliminary Approach by Urine Metabolomics

    Judit Morello 1, Sara M. Teixeira 1, João Rodrigues 2, Sara Maia 3, Atlas Sardoo 4, Rita Pinheiro Torres 5, Sofia A. Pereira 4, Jaime Branco 6, Alexandra Antunes 7 and Fernando Pimentel-Santos4, 1Centro de Química Estrutural, Instituto Superior Técnico, Ulisboa, Lisboa, Portugal, 2Clarify Analytical, Évora, Portugal, 3CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Lisbon, Lisbon, Portugal, 4Centro de Estudos de Doenças Crónicas (CEDOC), Nova Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisboa, Portugal, lisboa, Portugal, 5Rheumatology Department, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental; CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Lisbon., Lisbon, Portugal, 6CEDOC, NOVA-Medical School | Hospital Egas Moniz, CHLO, Lisbon, Lisbon, Portugal, 7Centro de Química Estrutural, Instituto Superior Técnico, Ulisboa,, Lisboa, Portugal

    Background/Purpose: Early diagnosis of inflammatory rheumatic diseases (IRD), as axial Spondyloarthritis (axSpA), Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) represents in our days a…
  • Abstract Number: 2496 • 2019 ACR/ARP Annual Meeting

    Serum Metabolomic Analysis of Psoriatic Arthritis Using Solid Phase Microextraction – Liquid Chromatography – High-Resolution Mass Spectrometry Identifies Putative Disease Activity Markers

    Vinod Chandran1, Nikita Looby 2, Nathaly Reyes-Garces 2, Rohan Machhar 3, Miao Yu 2, Anna Roszkowska 2, Janusz Pawliszyn 2 and Vathany Kulasingam 4, 1University Health Network, University of Toronto, Toronto, Canada, 2University of Waterloo, Waterloo, ON, Canada, 3Krembil Research Institute, University Health Network, Toronto, Canada, 4University of Toronto, Toronto, ON, Canada

    Background/Purpose: Disease activity in psoriatic arthritis (PsA) is often difficult to assess but drives treatment decisions, joint damage and long-term outcomes. We aimed to identify…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology